Heraeus Medical LLC Acquires Synthecure^® from Austin Medical Ventures

Heraeus Medical LLC based in Yardley (PA, USA) and legal entity of Heraeus Medical based in Wehrheim (Germany) has acquired the product Synthecure^® from Austin Medical Ventures. Heraeus Medical is a leading provider of bone cements and biomaterials for surgical orthopedics and trauma surgery and an expert in infection management. The distribution and commercial activities of the Synthecure^® product portfolio have already been transferred to Heraeus Medical LLC.

Synthecure^® is a 100% synthetic, medical grade calcium sulfate bone void filler that can be used directly at the site of infection in bone cavities and defects. It was developed by Austin Medical Ventures, Inc for optimal handling with established fast curing times and an innovative kit design to best meet the needs of surgeons. Synthecure^® has been cleared by the FDA and has multiple US patents and peer-reviewed publications. Currently, product sales are focused on the US market. Further information on the acquisition and its terms will not be disclosed.

With this acquisition, Heraeus Medical is continuing its global growth strategy by expanding its portfolio in the field of bioresorbables and infection management with the aim to meet the critical needs of today’s orthopedic patients. This significant milestone also represents a vertical portfolio expansion as it allows Heraeus Medical to gain access to new market segments within orthopedic trauma and foot & ankle surgery.